Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies

10.1084/jem.20171960

Saved in:
Bibliographic Details
Main Authors: Saei, A, Palafox, M, Benoukraf, T, Kumari, N, Jaynes, P.W, Iyengar, P.V, Muñoz?Couselo, E, Nuciforo, P, Cortés, J, Nötzel, C, Kumarakulasinghe, N.B, Richard, J.L.C, Isa, Z.F.B.A, Pang, B, Guzman, M, Siqin, Z, Yang, H, Tam, W.L, Serra, V, Eichhorn, P.J.A
Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
Format: Article
Published: Rockefeller University Press 2020
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/175109
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-175109
record_format dspace
spelling sg-nus-scholar.10635-1751092024-04-22T03:33:48Z Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies Saei, A Palafox, M Benoukraf, T Kumari, N Jaynes, P.W Iyengar, P.V Muñoz?Couselo, E Nuciforo, P Cortés, J Nötzel, C Kumarakulasinghe, N.B Richard, J.L.C Isa, Z.F.B.A Pang, B Guzman, M Siqin, Z Yang, H Tam, W.L Serra, V Eichhorn, P.J.A CANCER SCIENCE INSTITUTE OF SINGAPORE DUKE-NUS MEDICAL SCHOOL PATHOLOGY BIOCHEMISTRY PHARMACOLOGY B Raf kinase F box/WD repeat containing protein 7 FBXW7 protein, human glycine rigosertib sulfone ubiquitin thiolesterase USP28 protein, human vemurafenib analogs and derivatives animal apoptosis deficiency down regulation drug effect drug resistance gene deletion HEK293 cell line human MAPK signaling melanoma metabolism mouse pathology prognosis protein degradation protein stability tumor cell line Animals Apoptosis Cell Line, Tumor Down-Regulation Drug Resistance, Neoplasm F-Box-WD Repeat-Containing Protein 7 Gene Deletion Glycine HEK293 Cells Humans MAP Kinase Signaling System Melanoma Mice Prognosis Protein Stability Proteolysis Proto-Oncogene Proteins B-raf Sulfones Ubiquitin Thiolesterase Vemurafenib 10.1084/jem.20171960 Journal of Experimental Medicine 215 7 1913-1928 2020-09-09T03:46:13Z 2020-09-09T03:46:13Z 2018 Article Saei, A, Palafox, M, Benoukraf, T, Kumari, N, Jaynes, P.W, Iyengar, P.V, Muñoz?Couselo, E, Nuciforo, P, Cortés, J, Nötzel, C, Kumarakulasinghe, N.B, Richard, J.L.C, Isa, Z.F.B.A, Pang, B, Guzman, M, Siqin, Z, Yang, H, Tam, W.L, Serra, V, Eichhorn, P.J.A (2018). Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies. Journal of Experimental Medicine 215 (7) : 1913-1928. ScholarBank@NUS Repository. https://doi.org/10.1084/jem.20171960 0022-1007 https://scholarbank.nus.edu.sg/handle/10635/175109 Rockefeller University Press Unpaywall 20200831
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic B Raf kinase
F box/WD repeat containing protein 7
FBXW7 protein, human
glycine
rigosertib
sulfone
ubiquitin thiolesterase
USP28 protein, human
vemurafenib
analogs and derivatives
animal
apoptosis
deficiency
down regulation
drug effect
drug resistance
gene deletion
HEK293 cell line
human
MAPK signaling
melanoma
metabolism
mouse
pathology
prognosis
protein degradation
protein stability
tumor cell line
Animals
Apoptosis
Cell Line, Tumor
Down-Regulation
Drug Resistance, Neoplasm
F-Box-WD Repeat-Containing Protein 7
Gene Deletion
Glycine
HEK293 Cells
Humans
MAP Kinase Signaling System
Melanoma
Mice
Prognosis
Protein Stability
Proteolysis
Proto-Oncogene Proteins B-raf
Sulfones
Ubiquitin Thiolesterase
Vemurafenib
spellingShingle B Raf kinase
F box/WD repeat containing protein 7
FBXW7 protein, human
glycine
rigosertib
sulfone
ubiquitin thiolesterase
USP28 protein, human
vemurafenib
analogs and derivatives
animal
apoptosis
deficiency
down regulation
drug effect
drug resistance
gene deletion
HEK293 cell line
human
MAPK signaling
melanoma
metabolism
mouse
pathology
prognosis
protein degradation
protein stability
tumor cell line
Animals
Apoptosis
Cell Line, Tumor
Down-Regulation
Drug Resistance, Neoplasm
F-Box-WD Repeat-Containing Protein 7
Gene Deletion
Glycine
HEK293 Cells
Humans
MAP Kinase Signaling System
Melanoma
Mice
Prognosis
Protein Stability
Proteolysis
Proto-Oncogene Proteins B-raf
Sulfones
Ubiquitin Thiolesterase
Vemurafenib
Saei, A
Palafox, M
Benoukraf, T
Kumari, N
Jaynes, P.W
Iyengar, P.V
Muñoz?Couselo, E
Nuciforo, P
Cortés, J
Nötzel, C
Kumarakulasinghe, N.B
Richard, J.L.C
Isa, Z.F.B.A
Pang, B
Guzman, M
Siqin, Z
Yang, H
Tam, W.L
Serra, V
Eichhorn, P.J.A
Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
description 10.1084/jem.20171960
author2 CANCER SCIENCE INSTITUTE OF SINGAPORE
author_facet CANCER SCIENCE INSTITUTE OF SINGAPORE
Saei, A
Palafox, M
Benoukraf, T
Kumari, N
Jaynes, P.W
Iyengar, P.V
Muñoz?Couselo, E
Nuciforo, P
Cortés, J
Nötzel, C
Kumarakulasinghe, N.B
Richard, J.L.C
Isa, Z.F.B.A
Pang, B
Guzman, M
Siqin, Z
Yang, H
Tam, W.L
Serra, V
Eichhorn, P.J.A
format Article
author Saei, A
Palafox, M
Benoukraf, T
Kumari, N
Jaynes, P.W
Iyengar, P.V
Muñoz?Couselo, E
Nuciforo, P
Cortés, J
Nötzel, C
Kumarakulasinghe, N.B
Richard, J.L.C
Isa, Z.F.B.A
Pang, B
Guzman, M
Siqin, Z
Yang, H
Tam, W.L
Serra, V
Eichhorn, P.J.A
author_sort Saei, A
title Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
title_short Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
title_full Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
title_fullStr Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
title_full_unstemmed Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
title_sort loss of usp28-mediated braf degradation drives resistance to raf cancer therapies
publisher Rockefeller University Press
publishDate 2020
url https://scholarbank.nus.edu.sg/handle/10635/175109
_version_ 1800914342128910336